Brought to you by 
AbbVie, Pure MHC sign cancer alliance
Jan 2017
Executive Summary
Pure Protein LLC's subsidiary Pure MHC LLC is teaming up with AbbVie Inc. in the discovery and validation of peptide targets for use with T-cell receptor therapies aimed at various cancers.
Deal Industry
-
Biotechnology
- Large Molecule
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Alliance
- R+D and Marketing-Licensing
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
Advertisement
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
AbbVie, Pure MHC sign cancer alliance
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice